{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:32:18Z","timestamp":1789853538248,"version":"4.0.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1097\/01.mco.0000078983.18774.cc","type":"journal-article","created":{"date-parts":[[2011,4,10]],"date-time":"2011-04-10T05:34:42Z","timestamp":1302413682000},"page":"401-406","source":"Crossref","is-referenced-by-count":76,"title":["Cytokines in the pathogenesis of cancer cachexia"],"prefix":"10.1097","volume":"6","author":[{"given":"Josep M.","family":"Argil\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Busquets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"L\u00f3pez-Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210204","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-5273(02)00235-8","article-title":"Cancer cachexia.","volume":"85","author":"Fearon","year":"2002","journal-title":"Int J Cardiol"},{"key":"R2-8-20210204","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00075197-200005000-00003","article-title":"Cancer cachexia: from experimental models to patient management.","volume":"3","author":"Costelli","year":"2000","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R3-8-20210204","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<726::AID-IJC10>3.0.CO;2-Q","article-title":"Leptin and tumour growth in the rat.","volume":"81","author":"Lopez-Soriano","year":"1999","journal-title":"Int J Cancer"},{"key":"R4-8-20210204","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0899-9007(01)00730-4","article-title":"Does leptin really influence cancer anorexia?","volume":"18","author":"Sato","year":"2002","journal-title":"Nutrition"},{"key":"R5-8-20210204","first-page":"657","article-title":"Plasma concentration of leptin, neuropeptide Y and tumor necrosis factor alpha in patients with cancers, before and after radio- and chemotherapy.","volume":"106","author":"Kowalczuk","year":"2001","journal-title":"Pol Arch Med Wewn"},{"key":"R6-8-20210204","first-page":"421","article-title":"Leptin expression in colorectal and breast cancer patients.","volume":"5","author":"Tessitore","year":"2000","journal-title":"Int J Mol Med"},{"key":"R7-8-20210204","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jcem.86.1.7104","article-title":"Weight loss is not associated with hyperleptinemia in humans with pancreatic cancer.","volume":"86","author":"Brown","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-8-20210204","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/cyto.2002.1051","article-title":"Leptin role in advanced lung cancer: a mediator of the acute phase response or a marker of the status of nutrition?","volume":"19","author":"Aleman","year":"2002","journal-title":"Cytokine"},{"key":"R9-8-20210204","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s001090000137","article-title":"Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites.","volume":"78","author":"Mantovani","year":"2000","journal-title":"J Mol Med"},{"key":"R10-8-20210204","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s001090100234","article-title":"Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites.","volume":"79","author":"Mantovani","year":"2001","journal-title":"J Mol Med"},{"key":"R11-8-20210204","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0899-9007(00)00413-5","article-title":"Central nervous system mechanisms contributing to the cachexia-anorexia syndrome.","volume":"16","author":"Plata-Salaman","year":"2000","journal-title":"Nutrition"},{"key":"R12-8-20210204","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/0024-3205(94)90144-9","article-title":"Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorectic tumor-bearing rats.","volume":"54","author":"Chance","year":"1994","journal-title":"Life Sci"},{"key":"R13-8-20210204","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0196-9781(99)00183-7","article-title":"Effect of cytokines on hypothalamic neuropeptide Y release in vitro.","volume":"21","author":"King","year":"2000","journal-title":"Peptides"},{"key":"R14-8-20210204","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0899-9007(01)00727-4","article-title":"Neurochemical mechanisms for cancer anorexia.","volume":"18","author":"Laviano","year":"2002","journal-title":"Nutrition"},{"key":"R15-8-20210204","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1046\/j.1471-4159.2001.00639.x","article-title":"Cachexia in MAC16 adenocarcinoma: suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y.","volume":"79","author":"Bing","year":"2001","journal-title":"J Neurochem"},{"key":"R16-8-20210204","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI116816","article-title":"Suramin interfers with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.","volume":"92","author":"Strassmann","year":"1993","journal-title":"J Clin Invest"},{"key":"R17-8-20210204","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1525-1373.2000.22326.x","article-title":"A model that reproduces syndromes associated with human multiple myeloma in nonirradiated SCID mice.","volume":"223","author":"Barton","year":"2000","journal-title":"Proc Soc Exp Biol Med"},{"key":"R18-8-20210204","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/cyto.2001.0968","article-title":"Cancer cachexia is mediated in part by the induction of IL-6-like cytokines from the spleen.","volume":"16","author":"Barton","year":"2001","journal-title":"Cytokine"},{"key":"R19-8-20210204","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/cyto.2001.0899","article-title":"Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours.","volume":"15","author":"Negri","year":"2001","journal-title":"Cytokine"},{"key":"R20-8-20210204","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0277-5379(91)90483-T","article-title":"Anti-interferon- antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia.","volume":"27","author":"Matthys","year":"1991","journal-title":"Eur J Cancer"},{"key":"R21-8-20210204","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1006\/cyto.1996.0104","article-title":"Physiological effects of CNTF-induced wasting.","volume":"8","author":"Henderson","year":"1996","journal-title":"Cytokine"},{"key":"R22-8-20210204","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/cyto.1999.0516","article-title":"Effects of ciliary neurotrophic factor (CNTF) on protein turnover in cultured muscle cells.","volume":"12","author":"Wang","year":"2000","journal-title":"Cytokine"},{"key":"R23-8-20210204","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0014-5793(98)01485-9","article-title":"In the rat, TNF- administration results in an increase in both UCP2 and UCP3 mRNAs in skeletal muscle: a possible mechanism for cytokine-induced thermogenesis?","volume":"440","author":"Busquets","year":"1998","journal-title":"FEBS Lett"},{"key":"R24-8-20210204","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S1097-2765(01)00390-2","article-title":"Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1.","volume":"8","author":"Puigserver","year":"2001","journal-title":"Mol Cell"},{"key":"R25-8-20210204","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00075197-199805000-00002","article-title":"Catabolic proinflammatory cytokines.","volume":"1","author":"Argiles","year":"1998","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R26-8-20210204","doi-asserted-by":"crossref","first-page":"39259","DOI":"10.1074\/jbc.M105335200","article-title":"Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor B-independent bone morphogenetic proteinsmad signaling.","volume":"42","author":"Chen","year":"2001","journal-title":"J Biol Chem"},{"key":"R27-8-20210204","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","article-title":"NF-B-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.","volume":"289","author":"Guttridge","year":"2000","journal-title":"Science"},{"key":"R28-8-20210204","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.gt.3300819","article-title":"Intratumoral injection of oligonucleotides to the NFB binding site inhibits cachexia in a mouse tumor model.","volume":"6","author":"Kawamura","year":"1999","journal-title":"Gene Ther"},{"key":"R29-8-20210204","doi-asserted-by":"crossref","first-page":"R1518","DOI":"10.1152\/ajpregu.2001.280.5.R1518","article-title":"Increased muscle ubiquitin mRNA levels in gastric cancer patients.","volume":"280","author":"Bossola","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R30-8-20210204","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0899-9007(00)00407-X","article-title":"Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia.","volume":"16","author":"Baracos","year":"2000","journal-title":"Nutrition"},{"key":"R31-8-20210204","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0167-4889(01)00167-7","article-title":"Tumor necrosis factor-alpha exerts interleukin-6-dependent and -independent effects on cultured skeletal muscle cells.","volume":"1542","author":"Alvarez","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"R32-8-20210204","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0167-5273(02)00244-9","article-title":"Cytokines, apoptosis and cachexia: the potential for TNF antagonism.","volume":"85","author":"Sharma","year":"2002","journal-title":"Int J Cardiol"},{"key":"R33-8-20210204","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1006\/bbrc.2000.2462","article-title":"DNA fragmentation occurs in skeletal muscle during tumor growth: a link with cancer cachexia?","volume":"270","author":"van Royen","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"R34-8-20210204","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1054\/bjoc.2001.1700","article-title":"Cleavage of caspases-1, 3, 6, 8 and 9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia.","volume":"84","author":"Belizario","year":"2001","journal-title":"Br J Cancer"},{"key":"R35-8-20210204","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/sj.bjc.6600167","article-title":"TNF- is involved in activating DNA fragmentation in murine skeletal muscle.","volume":"86","author":"Carbo","year":"2002","journal-title":"Br J Cancer"},{"key":"R36-8-20210204","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00003495-200060020-00003","article-title":"Potential novel uses of thalidomide: focus on palliative care.","volume":"60","author":"Peuckmann","year":"2000","journal-title":"Drugs"},{"key":"R37-8-20210204","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1172\/JCI116897","article-title":"Tumor necrosis factor- mediates changes in tissue protein turnover in a rat cancer cachexia model.","volume":"92","author":"Costelli","year":"1993","journal-title":"J Clin Invest"},{"key":"R38-8-20210204","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00003246-199605000-00003","article-title":"Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.","volume":"24","author":"Reinhart","year":"1996","journal-title":"Crit Care Med"},{"key":"R39-8-20210204","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/(SICI)1097-0215(19960917)67:6<849::AID-IJC15>3.0.CO;2-X","article-title":"Murine interleukin-12 prevents the development of cancer cachexia in a murine model.","volume":"67","author":"Mori","year":"1996","journal-title":"Int J Cancer"},{"key":"R40-8-20210204","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1210\/endo.136.8.7628408","article-title":"Interleukin-15: a novel anabolic cytokine for skeletal muscle.","volume":"136","author":"Quinn","year":"1995","journal-title":"Endocrinology"},{"key":"R41-8-20210204","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1054\/bjoc.2000.1299","article-title":"Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats.","volume":"83","author":"Carbo","year":"2000","journal-title":"Br J Cancer"},{"key":"R42-8-20210204","first-page":"369","article-title":"NSAID zaltoprofen improves the decrease in body weight in rodent sickness behavior models: proposed new applications of NSAID.","volume":"9","author":"Okamoto","year":"2002","journal-title":"Int J Mol Med"},{"key":"R43-8-20210204","first-page":"382","article-title":"Cytokines in experimental cancer cachexia.","volume":"23","author":"Niu","year":"2001","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"R44-8-20210204","first-page":"5488","article-title":"Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia.","volume":"60","author":"Cahlin","year":"2000","journal-title":"Cancer Res"}],"container-title":["Current Opinion in Clinical Nutrition &amp; Metabolic Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mco.0000078983.18774.cc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:04:09Z","timestamp":1786043049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00075197-200307000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mco.0000078983.18774.cc","relation":{},"ISSN":["1363-1950"],"issn-type":[{"value":"1363-1950","type":"print"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}